Abstract:Primary ovarian insufficiency (POI) is one of the many unintended consequences of chemotherapy faced by the growing number of female cancer survivors. While ovarian repercussions of chemotherapy have long been recognized, the acute insult phase and primary sites of damage are not well-studied, hampering efforts to design effective intervention therapies to protect the ovary. Utilizing doxorubicin (DXR) as a model chemotherapy agent, we defined the acute timeline for drug accumulation, induced DNA damage, and s… Show more
“…Moreover, an apparent increase in the H2AXph139 was also observed in the presence of positive foci in the granulosa cells of the primordial follicles, oocytes from the developing follicles and in the stromal cells post treatment with 0.03µg/mL DXR. On the other hand, Roti et al, () did not observe an increase in the TUNEL and H2AXph139 positive foci in the primordial follicles after 48 hours of treatment in mice treated with 20 mg/kg of DXR. This study indicates that the DNA damage in the primordial follicles is only observed after a long exposure to DXR.…”
Section: Discussionmentioning
confidence: 90%
“…DXR acts by blocking the topoisomerase II action and inducing the production of the reactive oxygen species, which triggers cell death by blocking the protein synthesis and promoting oxidative damage (Tokarska et al, ). Studies in vivo on the DXR action (20 mg/kg) on mice ovary, showed that the accumulation of this drug in the follicles varies with the developmental stage in which the larger follicles (secondary, tertiary and antral) accumulated significantly more doxorubicin than did the smaller follicles (primordial and primary) (Roti et al, ). In the present study it was also observed that the developing preantral follicles cultured with 0.03 µg/mL DXR, had a higher number of foci positive for active caspase‐3 and H2AXph139 compared with those treated with PTX (0.1 or 0.001 µg/mL).…”
Section: Discussionmentioning
confidence: 99%
“…Recent advances in the treatment of neoplastic diseases have increased the long‐term survival of patients undergoing chemo‐radiotherapy (Roti et al, ). However, the utilization of cancer medications can lead to gonadal failure and affect all aspects of reproductive health, including prepubescent development, hormone production, and sexual functioning in adults.…”
“…Moreover, an apparent increase in the H2AXph139 was also observed in the presence of positive foci in the granulosa cells of the primordial follicles, oocytes from the developing follicles and in the stromal cells post treatment with 0.03µg/mL DXR. On the other hand, Roti et al, () did not observe an increase in the TUNEL and H2AXph139 positive foci in the primordial follicles after 48 hours of treatment in mice treated with 20 mg/kg of DXR. This study indicates that the DNA damage in the primordial follicles is only observed after a long exposure to DXR.…”
Section: Discussionmentioning
confidence: 90%
“…DXR acts by blocking the topoisomerase II action and inducing the production of the reactive oxygen species, which triggers cell death by blocking the protein synthesis and promoting oxidative damage (Tokarska et al, ). Studies in vivo on the DXR action (20 mg/kg) on mice ovary, showed that the accumulation of this drug in the follicles varies with the developmental stage in which the larger follicles (secondary, tertiary and antral) accumulated significantly more doxorubicin than did the smaller follicles (primordial and primary) (Roti et al, ). In the present study it was also observed that the developing preantral follicles cultured with 0.03 µg/mL DXR, had a higher number of foci positive for active caspase‐3 and H2AXph139 compared with those treated with PTX (0.1 or 0.001 µg/mL).…”
Section: Discussionmentioning
confidence: 99%
“…Recent advances in the treatment of neoplastic diseases have increased the long‐term survival of patients undergoing chemo‐radiotherapy (Roti et al, ). However, the utilization of cancer medications can lead to gonadal failure and affect all aspects of reproductive health, including prepubescent development, hormone production, and sexual functioning in adults.…”
“…CIS also increases phosphorylation of components of the PTEN/Akt/FOXO3a pathway that regulates growth activation of primordial follicles (Chang et al 2015, Jang et al 2016. DOX induces DNA damage in somatic cells (Roti Roti et al 2012, Xiao et al 2017. Apoptosis and proliferation of ovarian cortical stromal tissue was affected by drug exposure.…”
Chemotherapy drugs are administered to patients using combination regimens, and as such the possibility of multiplicative effects between drugs need to be investigated. This study examines the individual and combined effects of the chemotherapy drugs cisplatin and doxorubicin on the human ovary. Although cisplatin and doxorubicin are known to affect female fertility, there is limited information about their direct effects on the human ovary, and none examining the possibility of combined, multiplicative effects of co-exposure to these drugs. Here, human ovarian biopsies were obtained from 14 women at the time of caesarean section, with 38 mouse ovaries also obtained from neonatal C57Bl/6J mice. Tissue was cultured for 6 days prior to analyses, with chemotherapy drugs added to culture medium on the second day of culture only. Treatment groups of a single (5 μg/mL human; 0.5 μg/mL mouse) or double (10 μg/mL human; 1.0 μg/mL mouse) dose of cisplatin, a single (1 μg/mL human; 0.05 μg/mL mouse) or double (2 μg/mL human; 0.01 μg/mL mouse) dose of doxorubicin or a combination of a single dose of both drugs together were compared to controls without drug exposure. Exposure to cisplatin or doxorubicin significantly decreased follicle health in human and mouse, supporting the suitability of the mouse as a model for the human ovary. There was also a significant reduction of mouse follicle number. Human ovarian stromal tissue exhibited increased apoptosis and decreased cell proliferation. Crucially, there was no evidence indicating the occurrence of multiplicative effects between cisplatin and doxorubicin.
“…The exposure of parents to environmental toxicants, such as polycyclic aromatic hydrocarbons (Einaudi et al, 2014;Perrin et al, 2011), Bisphenol A (Goldstone et al, 2015), solvents (Kolstad et al, 1999), metals (Thompson and Bannigan, 2008;Zhou et al, 2016) or various therapies (Bujan et al, 2014;Esquerré-Lamare et al, 2015;Pecou et al, 2009;Roti Roti et al, 2012) may induce DNA damage in male and female germ cells. DNA damage in parental germ cells can lead to reproductive issues, such as reduced fertilization, impaired early embryonic development, a decreased pregnancy rate and increased miscarriage rate (Simon et al, 2014;Zhao et al, 2014).…”
1) The recovery rate was 3,3% (n=5/150) with the 2 agarose layers protocol and 71,3% (n=266/371) with the 3 agarose layers protocol. 2) DNA damage did not differ statistically significantly between ZP- and ZP+ embryos (12.60±2.53% Tail DNA vs 11.04±1.50 (p=0.583) for the control group and 49.23±4.16 vs 41.13±4.31 (p=0.182) for the HO group); 3) HO and SSI induced a statistically significant increase in DNA damage compared with the control group (41.13±4.31% Tail DNA, 36.33±3.02 and 11.04±1.50 (p<0.0001)). The CA on mammal embryos was optimized by using thawed embryos, by avoiding ZP removal and by the adjunction of a third agarose layer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.